{"id":"NCT00236977","sponsor":"American Regent, Inc.","briefTitle":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","officialTitle":"Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-08","primaryCompletion":"2004-10","completion":"2004-10","firstPosted":"2005-10-12","resultsPosted":"2010-03-09","lastUpdate":"2020-10-06"},"enrollment":182,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia"],"interventions":[{"type":"DRUG","name":"Venofer","otherNames":["iron sucrose tablets"]},{"type":"DRUG","name":"Ferrous Sulfate","otherNames":["Oral Iron Tablets"]}],"arms":[{"label":"Venofer","type":"EXPERIMENTAL"},{"label":"Ferrous Sulfate","type":"ACTIVE_COMPARATOR"}],"summary":"To assess the safety and efficacy of two forms of iron therapy for the treatment of anemia in non-dialysis dependent, chronic renal failure in patients receiving or not receiving erythropoietin.","primaryOutcome":{"measure":"Patients With an Increase in Hemoglobin >= 1gm/dL.","timeFrame":"Change from Baseline up to Day 56","effectByArm":[{"arm":"Venofer","deltaMin":35,"sd":null},{"arm":"Ferrous Sulfate","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["16316362"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":91},"commonTop":["Constipation","Diarrhea NOS","Nausea","Oedema NOS","Fatigue"]}}